Phospho Casein Kinase II α (Y255) Cell-Based Colorimetric ELISA Kit
- Catalog No.:KA1527C
- Applications:ELISA
- Reactivity:Human;Mouse;Rat
- Gene Name:
- CSNK2A1
- Human Gene Id:
- 1457
- Human Swiss Prot No:
- P68400
- Mouse Swiss Prot No:
- Q60737
- Rat Swiss Prot No:
- P19139
- Storage Stability:
- 2-8°C/6 months
- Other Name:
- Casein kinase II subunit alpha (CK II alpha) (EC 2.7.11.1)
- Detection Method:
- Colorimetric
- Background:
- catalytic activity:ATP + a protein = ADP + a phosphoprotein.,function:Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha and alpha' chains contain the catalytic site. Participates in Wnt signaling. CK2 phosphorylates 'Ser-392' of p53/TP53 following UV irradiation.,similarity:Belongs to the protein kinase superfamily.,similarity:Belongs to the protein kinase superfamily. Ser/Thr protein kinase family. CK2 subfamily.,similarity:Contains 1 protein kinase domain.,subunit:Tetramer composed of an alpha chain, an alpha' and two beta chains. Also component of a CK2-SPT16-SSRP1 complex composed of SSRP1, SUPT16H, CSNK2A1, CSNK2A2 and CSNK2B, the complex associating following UV irradiation. Interacts with RNPS1.,
- Function:
- protein amino acid phosphorylation, phosphorus metabolic process, phosphate metabolic process, cell surface receptor linked signal transduction, Wnt receptor signaling pathway, phosphorylation, protein amino acid autophosphorylation,
- Subcellular Location:
- Nucleus .
- Expression:
- Expressed in gastric carcinoma tissue and the expression gradually increases with the progression of the carcinoma (at protein level).
- June 19-2018
- WESTERN IMMUNOBLOTTING PROTOCOL
- June 19-2018
- IMMUNOHISTOCHEMISTRY-PARAFFIN PROTOCOL
- June 19-2018
- IMMUNOFLUORESCENCE PROTOCOL
- September 08-2020
- FLOW-CYTOMEYRT-PROTOCOL
- May 20-2022
- Cell-Based ELISA│解您多样本WB检测之困扰
- July 13-2018
- CELL-BASED-ELISA-PROTOCOL-FOR-ACETYL-PROTEIN
- July 13-2018
- CELL-BASED-ELISA-PROTOCOL-FOR-PHOSPHO-PROTEIN
- July 13-2018
- Antibody-FAQs